Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial

HIGHLIGHTS

• who: Gregory C. Shearer from the University of have published the research: Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial, in the Journal: (JOURNAL) of 10/Nov/2011
• future: These changes are consistent with a decrease in risk for coronary events however further prospective trials are necessary to confirm this.

SUMMARY

Sixty metabolic syndrome subjects were randomized to 16 weeks of treatment on dual placebo, P-OM3 (4g/day), ERN (2 g/day), or combination in a double . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.